Veterinary Medicines

Bovilis BVD Suspension for Injection for Cattle

Authorised
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Download as PDF

Product identification

Medicine name:
Bovilis BVD Suspension for injection for cattle
Bovilis BVD Suspension for Injection for Cattle
Active substance:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (dairy cow)
  • Cattle (calf)
  • Cattle (heifer)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
    50.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Cattle (for meat production)
      • Meat and offal
        no withdrawal period
    • Cattle (dairy cow)
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
    • Cattle (heifer)
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID7) 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 100 millilitre(s)
  • (ID6) 50 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 50 millilitre(s)
  • (ID1) 10 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 millilitre(s)
  • (ID20) 2 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 2 millilitre(s)
  • (ID30) 2 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 2 millilitre(s)
  • (ID3) 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s)
  • (ID9) 250 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 250 millilitre(s)
  • (ID4) 20 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 20 millilitre(s)
  • (ID2) 10 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 10 millilitre(s)
  • (ID5) 50 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 50 millilitre(s)
  • (ID8) 100 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 100 millilitre(s)
  • (ID10) 250 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 06376/3026
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0433/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)